Immunonutrition for Improving the Efficacy of Immunotherapy in Patients With Metastatic Non-small Cell Lung Cancer

The present study was designed to evaluate the efficacy of the early systematic provision of oral nutritional supplements enriched in immunonutrients in non-small lung cancer patients undergoing immunotherapy and receiving nutritional counseling

Trial Details

NCT ID
NCT05384873
Phase
NA
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • Immunonutrition
  • Control dietary intervention
Locations (sample)
  • Pavia, Italy|45.19205,9.15917

Key Eligibility Criteria

  • Confirmed histological diagnosis of metastatic non-small cell lung cancer (both squamous and non-squamous histology);
  • First-line treatment with immunotherapy (alone or in combination with chemotherapy) for metastatic disease by investigators' choice within the fram…
  • Will to participate by providing written informed consent;
  • Availability to administer oral supplements and immunotherapy with or without chemotherapy;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →